Gaza's cancer patients: Navigating the dual struggle of illness and war
Prof Philip Poortmans speaks to ecancer about tailoring radiation therapy in the 21st Century.
He initially talks about the background of his talk and then delves deeper into what tailoring radiation therapy according to the patient’s need means currently.
He talks about radiation doses and how to evaluate how much dosage is required by a patient.
Prof Poortmans concludes by talking about when dose de-escalation is useful and the different stages of cancer and how they are proportionate to the dosage amount.
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Antibody drug conjugates coming to primetime and new agents for breast cancer
Multiple myeloma (A cancer arising from plasma cells)
Multiple myeloma (A cancer arising from plasma cells)
IORT at Fortis Hospital Bangalore in India
Systemic anti-cancer performance matrix